Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynne Neumayr

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Hematology/Oncology Clinics of North America|April 30, 2019
Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under DevelopmentCarolyn Hoppe, Lynne Neumayr
Hematology/Oncology Clinics of North America|October 11, 2005
Bone and joint disease in sickle cell diseaseChristine Aguilar, Elliott Vichinsky, Lynne Neumayr
Transfusion|October 21, 2016
Erythrocytapheresis for chronic transfusion therapy in sickle cell disease: survey of current practices and review of the literatureShannon Kelly, Keith Quirolo, Anne Marsh, et al.
Pediatric Hematology and Oncology|May 24, 2017
Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experienceMichael Winstead, Peter P Sun, Kenneth Martin, et al.
Journal of the National Medical Association|December 15, 2010
Chart Card: feasibility of a tool for improving emergency department care in sickle cell diseaseLynne Neumayr, Steven Pringle, Stephen Giles, et al.
Pediatric Blood & Cancer|September 2, 2014
Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH)Susan T Paulukonis, William T Harris, Thomas D Coates, et al.
Blood Cells, Molecules & Diseases|November 16, 2012
Combined chelation therapy with deferasirox and deferoxamine in thalassemiaAshutosh Lal, John Porter, Nancy Sweeters, et al.
Current Medical Research and Opinion|June 17, 2024
Overall survival of patients with CLL treated with ibrutinib in the first line compared to second-line ibrutinib after chemotherapy/chemoimmunotherapyTadeusz Robak, Michael Doubek, Emmanuelle Ferrant, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 2, 2011
Improved engraftment with minimal graft-versus-host disease after major histocompatibility complex-mismatched cord blood transplantation with photochemically treated donor lymphocytesBindu Kanathezhath, Myra Mizokami, Sharleny Stanislaus, et al.
Haematologica|May 7, 2013
A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodesClaudia R Morris, Frans A Kuypers, Lisa Lavrisha, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Hematology/Oncology Clinics of North America|April 30, 2019
Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under DevelopmentCarolyn Hoppe, Lynne Neumayr
Hematology/Oncology Clinics of North America|October 11, 2005
Bone and joint disease in sickle cell diseaseChristine Aguilar, Elliott Vichinsky, Lynne Neumayr
Transfusion|October 21, 2016
Erythrocytapheresis for chronic transfusion therapy in sickle cell disease: survey of current practices and review of the literatureShannon Kelly, Keith Quirolo, Anne Marsh, et al.
Pediatric Hematology and Oncology|May 24, 2017
Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experienceMichael Winstead, Peter P Sun, Kenneth Martin, et al.
Journal of the National Medical Association|December 15, 2010
Chart Card: feasibility of a tool for improving emergency department care in sickle cell diseaseLynne Neumayr, Steven Pringle, Stephen Giles, et al.
Pediatric Blood & Cancer|September 2, 2014
Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH)Susan T Paulukonis, William T Harris, Thomas D Coates, et al.
Blood Cells, Molecules & Diseases|November 16, 2012
Combined chelation therapy with deferasirox and deferoxamine in thalassemiaAshutosh Lal, John Porter, Nancy Sweeters, et al.
Current Medical Research and Opinion|June 17, 2024
Overall survival of patients with CLL treated with ibrutinib in the first line compared to second-line ibrutinib after chemotherapy/chemoimmunotherapyTadeusz Robak, Michael Doubek, Emmanuelle Ferrant, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 2, 2011
Improved engraftment with minimal graft-versus-host disease after major histocompatibility complex-mismatched cord blood transplantation with photochemically treated donor lymphocytesBindu Kanathezhath, Myra Mizokami, Sharleny Stanislaus, et al.
Haematologica|May 7, 2013
A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodesClaudia R Morris, Frans A Kuypers, Lisa Lavrisha, et al.
Pageof 3